COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2007, before the NASDAQ Global Market opens on Thursday, February 28, 2008. C. Randal Mills, Ph.D., President and Chief Executive Officer, will provide a company update and discuss results via a webcast and conference call on Thursday, February 28, 2008 at 9:00 a.m. EST. To access the webcast, visit the Investor Relations section of the company’s website at http://investor.osiris.com/events.cfm. Alternatively, callers may participate in the conference call by dialing (877) 604-9665 (U.S. participants) or (719) 325-4898 (international participants).
